# STOCKHOLM 1.0
#=GF ID   K-cyclin_vir_C
#=GF AC   PF09080.14
#=GF DE   K cyclin, C terminal
#=GF AU   Sammut SJ;0000-0003-4472-904X
#=GF SE   pdb_1g3n
#=GF GA   25.30 25.30;
#=GF TC   25.30 25.70;
#=GF NC   24.50 25.20;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch --cpu 4 -E 1000 -Z 75585367 HMM pfamseq
#=GF TP   Domain
#=GF WK   Cyclin
#=GF CL   CL0065
#=GF RN   [1]
#=GF RM   11124804
#=GF RT   Structural basis of inhibition of CDK-cyclin complexes by INK4
#=GF RT   inhibitors. 
#=GF RA   Jeffrey PD, Tong L, Pavletich NP; 
#=GF RL   Genes Dev. 2000;14:3115-3125.
#=GF DR   INTERPRO; IPR015164;
#=GF DR   SCOP; 1g3n; fa;
#=GF DR   SO; 0000417; polypeptide_domain;
#=GF CC   Members of this family adopt a secondary structure consisting of
#=GF CC   a five alpha-helix cyclin fold. Interaction with cyclin
#=GF CC   dependent kinases (CDKs) at a PSTAIRE sequence motif within the
#=GF CC   catalytic cleft of CDK results in the regulation of CDK activity
#=GF CC   [1].
#=GF SQ   2
#=GS O40946_HHV8/148-253       AC O40946.1
#=GS A0A5J6XWX3_9GAMA/148-246  AC A0A5J6XWX3.1
O40946_HHV8/148-253                  AVLATDVTSFLLLKLLGGSQHLDFWHHEVNTLITKALVDPKTGSLPASIISAAGCALLVPANVIPQDTHSGGVVPQLASILGCDVSVLQAAVEQILTSVSDFDL.RI
A0A5J6XWX3_9GAMA/148-246             AVLPTDAIGPTLFKSGFTKEQLFALHSQVVESVHKAIVNPATGGLPPSLVAAA.CALFSLGAAAPPPA.......RLAEAVGVSAATLAAAAESVATTLREFDEDRI
#=GC seq_cons                        AVLsTDshu.hLhK.hhspppL.hhHppVsp.lpKAlVsPtTGuLPsSlluAA.CALhs.usshP.ss.......pLAphlGsssusLtAAsEplhTolp-FD..RI
